X
Alnylam hopes for 2018 filing for RNAi liver disease drug
https://pharmaphorum.com/news/alnylam-hopes-2018-filing-rnai-liver-disease-drug/
Biotech
Epigenetics-focused biotech Constellation raises $100m
Constellation Pharmaceuticals, a company focused on developing small molecule therapies for difficult-to-treat cancers has raised $100 million from a group of old and new investors.
Mobile Clinical Trials EU
Combining best examples of mobile/digital optimization
Pharma AI & IoT 2018
AI & IoT
Fifth Annual Re-Entering Antibacterial Discovery and Development Summit
The Summit works to improve antimicrobial stewardship
NANO.IL.2018, the leading international nanotechnology conference in Israel
NANO.IL.2018 conference & exhibition
Chief Medical Officer Summit
Chief Medical Officer Summie, Boston.
Clinical Research as a Care Option
Bring Clinical Research Closer to Patients
How Will Spark’s Approval Impact the Gene Therapy Field?
Gene Therapy for Rare Disorders Summit
